6th Arab and Southern European Countries Masterclass in Clinical Oncology

Chairs: M.S. Aapro, CH - N. Pavlidis, GR
Co-chairs: J. Gligorov, FR - S. Khatib, JO
Host Chair: D. Papamichael, CY


This is a 3-days clinically oriented educational programme dedicated to medical, clinical and radiation oncologists, who wish to improve their skills in oncology. The programme focuses on breast, gynaecological, prostate, colorectal, lung cancers and on lymphomas and its covered by an international faculty of top experts.

The Masterclass offers:
• plenary lectures regarding state-of-the art clinical evaluation and treatments with reference to clinical guidelines concluding in take-home messages;
• clinical case presentations will be delivered by the participants in Tumor Board discussions as well as in divided small groups with the presence of the chairmen and the faculty;
• a self-assessment test based on multiple choice questionnaire, will be provided to participants on the last day of the Masterclass.

All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission.

AIMS AND OBJECTIVES
This clinically oriented educational programme has been designed for medical and clinical oncologists who wish to improve their skills in the management of cancer patients.
The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-orientated training. The programme focuses on breast, gynaecological, lung, urological and gastrointestinal cancers. Spotlight sessions will facilitate compact update on elderly patients, head and neck, melanoma, non-Hodgkin’s lymphoma, soft tissue sarcoma, supportive care.

LEARNING OBJECTIVES
• Improve medical and radiation oncologists’ skills
• Practicing case discussion
• Deep focus on breast, gynaecological, prostate, lung and colorectal cancer, lymphomas.

TEACHING FORMAT
The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and other evidence-based guidelines will be cited. Participants will deliver case presentations within tumour boards and discuss them with the chairs and the faculty.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.

THE MASTERCLASS:
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on breast, gynaecological, lung, urological and gastrointestinal cancers

MAIN TOPICS
• Breast cancer
• Gynaecological cancer
• Lung cancer
• Urological cancer
• Gastrointestinal cancer
• Lymphomas

Held in collaboration with								Held under the auspices of the Arab Medical Association Against Cancer (AMAAC)

GENERAL INFORMATION
Organising secretariat
Daniela Mengato
European School of Oncology (ESO)
Via Turati 29 - 20121 Milan, Italy
Tel: +39 02 85464523
Fax: +39 02 85464545
Email: dmengato@eso.net

Applications
Alice Ciocchini

Ph: +39 02 85464529

Email: aciocchini@eso.net

FACULTY
M.S. Aapro, Breast Center, Genolier, CH
D. Arnold, CUF Hospitals Cancer Center, Lisbon, PT
H. Azim, Cairo University, Cairo Oncology Center, EG
H. Boussen, Institut Salah Azaiz (ISA), Tunis, TN
M.J. Cardoso, Champalimaud Foundation, Lisbon, PT
P. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
A. Constantinidou, Medical School, University of Cyprus, Nicosia, CY
G. Curigliano, European Institute of Oncology, Milan, IT
R. Gaafar, National Cancer Institute, Cairo, EG
F. Geara, American University of Beirut, LB
J. Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, FR
J. Khader, King Hussein Cancer Center, Amman, JO
H. Khaled, National Cancer Institute, Cairo, EG
S. Khatib, Arab Medical Association Against Cancer (AMAAC), Amman, JO
O. Michielin, Lausanne University Hospital – CHUV, CH
N. Mottet, University Jean Monnet, Saint Etienne, FR
R. Orecchia, European Institute of Oncology, Milan, IT
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Pavlidis, University Hospital of Ioannina, GR
G. Pruneri, European Institute of Oncology, Milan, IT
R. Stahel, University Hospital Zurich, CH
A. Stathis, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
J.B. Vermorken, Antwerp University Hospital, BE

 14 December

 15 December

 16 December

 17 December

 18 December